ATE453328T1 - Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials - Google Patents

Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials

Info

Publication number
ATE453328T1
ATE453328T1 AT04768179T AT04768179T ATE453328T1 AT E453328 T1 ATE453328 T1 AT E453328T1 AT 04768179 T AT04768179 T AT 04768179T AT 04768179 T AT04768179 T AT 04768179T AT E453328 T1 ATE453328 T1 AT E453328T1
Authority
AT
Austria
Prior art keywords
providing
coating material
resistant coating
improved formulation
juice resistant
Prior art date
Application number
AT04768179T
Other languages
English (en)
Inventor
Vic Young
Original Assignee
Mw Encap Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE453328(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mw Encap Ltd filed Critical Mw Encap Ltd
Application granted granted Critical
Publication of ATE453328T1 publication Critical patent/ATE453328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A23P20/105—Coating with compositions containing vegetable or microbial fermentation gums, e.g. cellulose or derivatives; Coating with edible polymers, e.g. polyvinyalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Paints Or Removers (AREA)
AT04768179T 2003-08-27 2004-08-25 Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials ATE453328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320020.1A GB0320020D0 (en) 2003-08-27 2003-08-27 Improved formulation for providing an enteric coating material
PCT/GB2004/003623 WO2005020708A1 (en) 2003-08-27 2004-08-25 Improved formulation for providing an enteric coating material

Publications (1)

Publication Number Publication Date
ATE453328T1 true ATE453328T1 (de) 2010-01-15

Family

ID=28686399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768179T ATE453328T1 (de) 2003-08-27 2004-08-25 Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials

Country Status (6)

Country Link
US (2) US8846087B2 (de)
EP (1) EP1667533B2 (de)
AT (1) ATE453328T1 (de)
DE (1) DE602004024902D1 (de)
GB (1) GB0320020D0 (de)
WO (1) WO2005020708A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
US8123849B2 (en) * 2005-11-29 2012-02-28 Ideal Cures Pvt. Ltd. Aqueous film coating composition containing sodium alginate and preparation thereof
EP1837323A1 (de) * 2006-03-24 2007-09-26 SOLVAY (Société Anonyme) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluoropropan
CA2705518A1 (en) * 2007-11-13 2009-05-22 Hercules Incorporated Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms
EP2448566A2 (de) 2009-07-02 2012-05-09 Hercules Incorporated Stabile formulierung mit magensaftresistenter schellack-beschichtung für nutrazeutische und pharmazeutische dosierformen
WO2011100643A1 (en) 2010-02-12 2011-08-18 Sensient Colors Inc. Enteric coating compositions and methods of making and using the same
US20110269850A1 (en) * 2010-04-28 2011-11-03 Signorino Charles A Shellac enteric coatings
IT1401146B1 (it) * 2010-07-27 2013-07-12 Gnosis Spa Composizione comprendente shellac e/o un suo sale e sodio amido glicolato
BR112013003581B8 (pt) * 2010-08-18 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica gastro resistente, que compreende um ou mais sais do ácido algínico, e seu processo de produção
KR101973235B1 (ko) * 2012-08-27 2019-08-16 에보니크 룀 게엠베하 에탄올의 영향에 대해 지속 방출 특성 및 내성을 갖는 제약 또는 기능식품 조성물
EP2887925B1 (de) * 2012-08-27 2017-02-22 Evonik Röhm GmbH Magensaftresistente pharmazeutische oder nutrazeutische zusammensetzung mit resistenz gegenüber dem einfluss von ethanol
KR102201077B1 (ko) * 2013-03-08 2021-01-11 라이온 가부시키가이샤 코팅 조성물, 코팅 제제 및 그 제조 방법
CN104394898B (zh) * 2013-05-02 2017-10-13 卡迪奥诺沃姆有限公司 球囊表面涂层
WO2014177221A1 (en) * 2013-05-02 2014-11-06 Cardionovum Gmbh Balloon surface coating
WO2015120007A1 (en) 2014-02-05 2015-08-13 Sensient Colors Llc Surface-treated calcium carbonate, methods for making the same, and compositions including the same
WO2015134504A1 (en) * 2014-03-03 2015-09-11 Sensient Colors Llc Alcohol-resistant, dose dumping protective enteric drug film coating
JP7111104B2 (ja) * 2017-08-09 2022-08-02 ライオン株式会社 コーティング組成物、コーティング膜、コーティング製剤及びその製造方法
EP3473244A1 (de) 2017-10-20 2019-04-24 Veru Inc. Orales tamsulosinhydrochlorid mit kontrollierter freisetzung
EP3473245A1 (de) 2017-10-20 2019-04-24 Veru Inc. Orales tamsulosinhydrochlorid mit kontrollierter freisetzung
MX2020006460A (es) * 2017-12-22 2020-11-06 Chemocentryx Inc Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar.
US20230263739A1 (en) * 2020-06-26 2023-08-24 Sensient Colors Llc Enteric coating composition and method of making and using the same
EP4440553A1 (de) * 2021-12-03 2024-10-09 DSM IP Assets B.V. Neues abgabesystem für vitamin c

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126320A (en) † 1964-03-24 Enteric-coated tablets of dextran sul-
US3350329A (en) * 1967-02-01 1967-10-31 Gillespie Rogers Pyatt Co Inc Coating compositions, of shellac, melamine formaldehyde, and styrene-acrylate emulsions
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
AU466503B2 (en) † 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
GB8308508D0 (en) 1983-03-28 1983-05-05 Ici Plc Detergent compositions
US4778749A (en) * 1984-06-01 1988-10-18 Karyon Technology, Inc. Tissue culture and production in permeable gels
US4769168A (en) 1985-08-05 1988-09-06 Colgate-Palmolive Company Low phosphate or phosphate free nonaqueous liquid nonionic laundry detergent composition and method of use
IE63321B1 (en) 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
DE3610952A1 (de) * 1986-04-02 1987-10-08 Hagen Batterie Ag Verfahren zum herstellen von akkumulatoren mit akkumulatorplattensaetzen und nach diesem verfahren hergestellter akkumulator
AU7219094A (en) † 1993-07-14 1995-02-13 Opta Food Ingredients, Inc. Shellac dispersions and coatings, and method of making
US6083532A (en) † 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
AU747099B2 (en) * 1997-10-31 2002-05-09 Pharmacia Corporation Gellan gum tablet coating
KR19990072826A (ko) 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
EP0943242A1 (de) 1998-02-26 1999-09-22 Puratos N.V. Granuliertes Brotvergesserungmittel sowie ihre Verwendung zur Herstellung von Teigwaren
US6620431B1 (en) 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
JP2002193831A (ja) † 2000-12-27 2002-07-10 Fancl Corp ヘム鉄含有経口用組成物
US6759058B1 (en) 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
KR100474945B1 (ko) * 2002-01-10 2005-03-10 알앤엘생명과학주식회사 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
EP2448566A2 (de) 2009-07-02 2012-05-09 Hercules Incorporated Stabile formulierung mit magensaftresistenter schellack-beschichtung für nutrazeutische und pharmazeutische dosierformen

Also Published As

Publication number Publication date
DE602004024902D1 (de) 2010-02-11
US8846087B2 (en) 2014-09-30
EP1667533A1 (de) 2006-06-14
US9629802B2 (en) 2017-04-25
WO2005020708A1 (en) 2005-03-10
US20140377313A1 (en) 2014-12-25
EP1667533B2 (de) 2013-07-31
EP1667533B1 (de) 2009-12-30
US20070071821A1 (en) 2007-03-29
GB0320020D0 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
ATE453328T1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
TW200628159A (en) IL-12 modulatory compounds
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
TW200732349A (en) Anti-OX40L antibodies and methods using same
EA200600065A2 (ru) Гидрофобные композиционные и сыпучие материалы, их применение
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
CY1113074T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
TW201713640A (en) Bruton's tyrosine kinase inhibitors
NO20054093L (no) Fremgangsmate for fremstilling av keramiske partikler
EA200801406A1 (ru) Антагонисты активина-actriia и их применение для стимулирования роста кости
DK1458760T3 (da) Indfangede bindingsproteiner som biosensorer
DE602005014147D1 (de) Verfahren zur herstellung von hydrokolloiden
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
TW200720256A (en) IL-12 modulatory compounds
DE102005001078A8 (de) Glaspulver, insbesondere biologisch aktives Glaspulver und Verfahren zur Herstellung von Glaspulver, insbesondere biologisch aktivem Glaspulver
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
TW200607863A (en) Immune modulating compounds from fungi
EA201070680A1 (ru) Жесткий контейнер для пищевых продуктов, содержащих рыбу
UA96627C2 (ru) Сухой экстракт из pelargonium sidoides ta pelargonium reniforme, способ его получения и продукты на его основе
ATE485330T1 (de) Fluoriertes polyetherpolyamin und herstellungsverfahren dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties